Enovis Corp Accounts Receivable, Allowance for Credit Loss, Current
Enovis Corp (ENOV) had Accounts Receivable, Allowance for Credit Loss, Current of $28.18 million as of 2026-07-03, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-08-06
- 2026-07-03: Accounts Receivable, Allowance for Credit Loss, Current $28.18M.
- 2026-04-03: Accounts Receivable, Allowance for Credit Loss, Current $30.22M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $25.61M.
- 2025-10-03: Accounts Receivable, Allowance for Credit Loss, Current $26.64M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-07-03 | $28.18M 10-Q · filed 2026-08-06 | |
| 2026-04-03 | $30.22M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $25.61M 10-Q · filed 2026-08-06 | |
| 2025-10-03 | $26.64M 10-Q · filed 2025-11-06 | |
| 2025-07-04 | $28.18M 10-Q · filed 2025-08-07 | |
| 2025-04-04 | $26.85M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $24.47M 10-K · filed 2026-02-26 | |
| 2024-09-27 | $23.56M 10-Q · filed 2024-11-06 | |
| 2024-06-28 | $14.85M 10-Q · filed 2024-08-07 | |
| 2024-03-29 | $9.75M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $9.73M 10-K · filed 2025-02-26 | |
| 2023-09-29 | $8.71M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $8.16M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $8.06M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $7.96M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $7.52M 10-Q · filed 2022-11-02 | |
| 2022-07-01 | $8.18M 10-Q · filed 2022-08-04 | |
| 2022-04-01 | $37.87M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $6.59M 10-K · filed 2023-03-01 | $32.50M 10-K · filed 2022-02-22 |
| 2021-10-01 | $34.68M 10-Q · filed 2021-11-04 | |
| 2021-07-02 | $34.21M 10-Q · filed 2021-07-28 | |
| 2021-04-02 | $35.56M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $37.67M 10-K · filed 2022-02-22 | |
| 2020-10-02 | $34.98M 10-Q · filed 2020-10-29 | |
| 2020-07-03 | $32.38M 10-Q · filed 2020-08-06 | |
| 2020-04-03 | $30.56M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $32.63M 10-K · filed 2021-02-18 | |
| 2019-09-27 | $40.86M 10-Q · filed 2019-10-31 | |
| 2019-06-28 | $31.68M 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $41.54M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $26.84M 10-K · filed 2020-02-24 | $35.15M 10-K · filed 2019-02-21 |
| 2018-09-28 | $28.80M 10-Q · filed 2018-10-25 | |
| 2018-06-29 | $29.32M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $31.77M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $31.49M 10-K · filed 2019-02-21 | |
| 2017-09-29 | $30.04M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $40.93M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $42.31M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $29.00M 10-K · filed 2018-02-16 | $41.51M 10-K · filed 2017-02-14 |
| 2016-09-30 | $44.39M 10-Q · filed 2016-10-27 | |
| 2016-07-01 | $43.85M 10-Q · filed 2016-07-28 | |
| 2016-04-01 | $44.63M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $39.51M 10-K · filed 2017-02-14 | |
| 2015-09-25 | $36.91M 10-Q · filed 2015-10-22 | |
| 2015-06-26 | $24.34M 10-Q · filed 2015-07-23 | |
| 2015-03-27 | $25.31M 10-Q · filed 2015-04-23 | |
| 2014-12-31 | $27.26M 10-K · filed 2016-02-16 | |
| 2014-09-26 | $28.22M 10-Q · filed 2014-10-23 | |
| 2014-06-27 | $29.06M 10-Q · filed 2014-07-25 | |
| 2014-03-28 | $30.96M 10-Q · filed 2014-04-24 | |
| 2013-12-31 | $31.28M 10-K · filed 2015-02-17 | |
| 2013-09-27 | $18.43M 10-Q · filed 2013-10-24 | |
| 2013-06-28 | $18.65M 10-Q · filed 2013-07-25 | |
| 2013-03-29 | $16.30M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $16.46M 10-K · filed 2014-02-12 | |
| 2012-09-28 | $8.92M 10-Q · filed 2012-10-31 | |
| 2012-06-29 | $6.09M 10-Q · filed 2012-08-07 | |
| 2012-03-30 | $3.61M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $2.58M 10-K · filed 2013-02-19 | |
| 2011-09-30 | $2.71M 10-Q · filed 2011-10-27 | |
| 2011-07-01 | $2.87M 10-Q · filed 2011-07-29 | |
| 2010-12-31 | $2.56M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |